ROCHE GS's latest marketcap:
As of 08/02/2025, ROCHE GS's market capitalization has reached $275.12 B. According to our data, ROCHE GS is the 37th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | $275.12 B |
| Revenue (ttm) | $78.98 B |
| Net Income (ttm) | $11.73 B |
| Shares Out | 850.32 M |
| EPS (ttm) | $14.61 |
| Forward PE | 12.66 |
| Ex-Dividend Date | 03/27/2025 |
| Earnings Date | 07/24/2025 |
ROCHE GS's yearly market capitalization.
| Date | Market Cap(₣) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/02/2025 | ₣221.14 B | $275.12 B | 8.79% | 37 |
| 12/30/2024 | ₣205.19 B | $225.93 B | 4.12% | 47 |
| 12/29/2023 | ₣197.07 B | $234.07 B | -17.82% | 42 |
| 12/30/2022 | ₣239.81 B | $259.26 B | -21.84% | 31 |
| 12/30/2021 | ₣306.81 B | $336.29 B | 16.11% | 25 |
| 12/30/2020 | ₣264.24 B | $298.46 B | -1.32% | 25 |
| 12/30/2019 | ₣267.78 B | $276.37 B | 29.2% | 23 |
| 12/28/2018 | ₣207.26 B | $211.01 B | -1.44% | 25 |
| 12/29/2017 | ₣210.28 B | $215.52 B | 5.63% | 29 |
| 12/30/2016 | ₣199.08 B | $195.11 B | -15.41% | 27 |
Company Profile
About Roche Holding AG
Roche Holding AG is a global leader in pharmaceuticals and diagnostics, operating across Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
Pharmaceutical Solutions
The company specializes in therapeutic areas including:
- Anaemia and blood disorders
- Solid and hematologic tumors
- Dermatology and inflammatory diseases
- Haemophilia and autoimmune conditions
- Neurological and ophthalmological disorders
- Respiratory diseases and transplantation
Diagnostics & Digital Health
Roche provides advanced diagnostic solutions, such as:
- In vitro tests for cancer, diabetes, and infectious diseases (including Covid-19 and hepatitis)
- Cutting-edge diagnostic instruments
- Innovative digital health technologies
Founded in 1896, Roche is headquartered in Basel, Switzerland, and continues to drive advancements in healthcare worldwide.
Frequently Asked Questions
-
What is ROCHE GS's (SWX-ROG) current market cap?As of 08/02/2025, ROCHE GS (including the parent company, if applicable) has an estimated market capitalization of $275.12 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does ROCHE GS (SWX-ROG) rank globally by market cap?ROCHE GS global market capitalization ranking is approximately 37 as of 08/02/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.